← back to search

Russell R. Broaddus

L'Alliance Boviteq · US
Area of research
Pathology and Forensic Medicine · Cancer Research
Research interest
Research interests include Genetic factors in colorectal cancer, Cancer Genomics and Diagnostics, Endometrial and Cervical Cancer Treatments, and Ovarian cancer diagnosis and treatment.
h-index
101
citations
53,731
works
745
NIH funding
primary concept
email

Recent publications

Characterizing the Discordance between ARID1A Protein and Genotype in Endometrioid-Type Endometrial Tumors
The American Journal of Pathology 2026cited by 0position: contributordoi
Data from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2025cited by 0position: contributordoi
Supplementary Figures 1-6 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2025cited by 0position: contributordoi
Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2025cited by 0position: contributordoi
Table S2 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2025cited by 0position: contributordoi
Table S3 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2025cited by 0position: contributordoi
Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors.
2023cited by 11position: contributordoi
Supplementary Figures 1-6 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S2 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S3 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S3 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Supplementary Figures 1-6 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Data from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S2 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S3 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S2 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Supplementary Figures 1-6 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Data from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S3 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S1 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Table S2 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Supplementary Figures 1-6 from Comparative Tumor Microenvironment Analysis of Primary and Recurrent Ovarian Granulosa Cell Tumors
2023cited by 0position: contributordoi
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer
Archives of Pathology & Laboratory Medicine 2022cited by 137position: lastdoi
Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer
Cancer Letters 2021cited by 26position: middledoi
Endometrial Cancer
New England Journal of Medicine 2020cited by 649position: lastdoi
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
Cancer Cell 2020cited by 110position: middledoi
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Scientific Reports 2020cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 25 papers (2023–2026)P. Andrew Futreal · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)Samuel C. Mok · Houston Methodist24 papers (2023–2025)Curtis Gumbs · Center for Genomic Science24 papers (2023–2025) · 24 papers (2023–2025)Latasha Little · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)David Gershenson · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)Tri Nguyen · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)Thomas Welte · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)Bryan Fellman · Cancer Research And Biostatistics24 papers (2023–2025)Veena K. Vuttaradhi · Center for Genomic Science24 papers (2023–2025)Hannah C. Beird · Center for Genomic Science24 papers (2023–2025)Joseph Celestino · Gynecologic Oncology Group24 papers (2023–2025)Sammy Ferri-Borgogno · The University of Texas Health Science Center at Houston24 papers (2023–2025)Eleonora Khlebus · Center for Genomic Science24 papers (2023–2025)Namrata Khurana · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)Robert Hillman · The University of Texas MD Anderson Cancer Center24 papers (2023–2025)Barrett Lawson · Scripps MD Anderson Cancer Center24 papers (2023–2025)Alejandra Flores Legarreta · Gynecologic Oncology Group24 papers (2023–2025)Siqing Fu · The University of Texas MD Anderson Cancer Center5 papers (2014–2020)